We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Spinal Cord Stimulation Efficiency Boosted with Extra Implanted Electrodes

By HospiMedica International staff writers
Posted on 13 Mar 2012
A new study describes a method of electrical stimulation that uses an implanted device with three columns of electrodes, which could increase the efficiency of spinal cord stimulation (SCS) for severe back pain.

Researchers at Poitiers University (France) conducted a study involving 11 patients implanted with a 16-contact spinal cord stimulation lead to assess, through extensive stimulation testing, the capacity of multicolumn tripolar leads to achieve back territory paresthesia coverage in refractory failed back-surgery syndrome patients. More...
A systematic exploration of 43 selected stimulation configurations was used to generate bilateral back paresthesia in addition to leg territory coverage.

The results showed that the tripolar lead configuration successfully generated paresthesia in both bilateral back and leg territories in nine patients (81.8%). Success rates of multicolumn stimulation patterns were significantly higher than for longitudinal configurations for lombodorsal paresthesia coverage. Six months after implantation, significant pain relief was obtained compared with preoperative evaluation for global pain, leg pain, and back pain, as measured on the Visual Analog Scale (VAS). The study was published in the March 2012 issue of Neurosurgery.

“These results suggest that multicolumn leads can reliably generate back pain coverage and favor pain relief outcomes. This may lead physicians to reconsider new indications for spinal cord stimulation,” concluded lead author Philippe Rigoard, MD, and colleagues of the department of neurosurgery. “Expanding neurostimulation perspectives to intractable back pain syndromes could become realistic in the near future.”

For the study, the researchers used the Medtronic (Fridley, MN, USA) Specify 5-6-5 system, which is composed of 16 electrodes in a three-column configuration that offers overlapping areas of stimulation, therefore maximizing the impact of SCS. The tripolar lead configuration and stimulation patterns could potentially help in surpassing restrictions of earlier approaches to SCS, especially for axial pain.

Related Links:

Poitiers University
Medtronic



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.